严重喘的背景治疗在现实生活中的单克隆抗体治疗上
Filippo F Cosini1, Diego Bagnasco2, Fulvio Braido2
1S.C. Pneumologia, ASL2 Savonese, Savona, Italy.
Respiratory medicine
|January 6, 2025
概括
在用单克隆抗体 (MAbs) 治疗的严重喘患者中,减少吸入的皮质类固醇剂量是安全有效的. 这种方法可以保持喘的控制,即使在不坚持治疗的患者中也是如此.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 最近的全球喘倡议 (GINA) 准则建议在严重喘患者中减少吸入性皮质类固醇 (ICS) 剂量,这些患者对单克隆抗体 (MAbs) 产生反应.
- 这项研究评估了在GINA建议之前接受MAbs的队列中ICS剂量减少.
研究的目的:
- 分析了至少24个月用单克隆抗体治疗的严重喘患者减少吸入性皮质类固醇剂量的结果.
- 评估这种减轻对喘控制和患者坚持治疗的影响.
主要方法:
- 对63名接受MAb治疗的严重喘患者进行了回顾性分析,治疗时间为≥24个月.
- 从电子档案中收集的数据和6个月的随访,包括从药房声明中得出的依从性.
主要成果:
- 41%的喘完全缓解,61%的喘缓解到了GINA第三步.
- 45%的患者不坚持吸入和/或口服喘治疗.
- 在实现完全缓解的患者中,非坚持性更高 (59%对33%).
结论:
- 在MAbs治疗的严重喘患者中,从GINA第5步向第3步降低喘治疗是可行的.
- 这种减少策略不会对喘控制产生负面影响,无论患者是否坚持治疗.
更多相关视频
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
236
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
236
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
Antiasthma Drugs: β2-Adrenoceptor Agonists
231
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
231
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma: Pathogenesis and Management
346
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
346


